Lower screening age calls for more tailored bowel cancer surveillance

Published Date: 01 May 2025

Australia's recent move to lower the starting age for bowel (colorectal) cancer screening from 50 down to 45 years old will mean better outcomes—but it will also increase the burden on an already struggling health care ...

Read Full News

Latest News

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Todays Updates

NPM1-Mutated AML: Not All Treatments Are Equal

Researchers conducted a retrospective analysis of patients with newly diagnosed NPM1-mutated AML treated with high- or low-intensity regimens.

Transgender Individuals Prefer HPV Self-Swabs

Transgender and gender-diverse individuals prefer self-collected HPV testing for cervical cancer screening, a new survey shows.

Todays Updates

NPM1-Mutated AML: Not All Treatments Are Equal

Researchers conducted a retrospective analysis of patients with newly diagnosed NPM1-mutated AML treated with high- or low-intensity regimens.

Transgender Individuals Prefer HPV Self-Swabs

Transgender and gender-diverse individuals prefer self-collected HPV testing for cervical cancer screening, a new survey shows.

Latest News

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Consistently low PSA levels failed to signal metastasis

News All Time

Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening

News, features, and commentary about cancer-related issues

Tennessee Pharmacies Sell Potent Ivermectin Pushed by Anti-Vaccine Doctor

"I've taken bucketloads of this stuff," says Denise Sibley

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

A look at the "silent" impacts of cancer

More Data Back Teclistamab for Autoimmune Disease

Another case series shows most patients improved markedly after failing everything else

Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

Blood-based biomarker test had similar false-positive rate as PSA, while reducing false negatives

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

Health news and commentary gathered by MedPage Today staff

Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day

Editors "no longer have confidence in the integrity of the results"

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

Lymphoma-free survival exceeding 5 years in early recipients of the cellular therapy

I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.

And the fundamental question remains of whether doctors should be involved at all

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

News, features, and commentary about cancer-related issues

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

The presence of a beloved pet can ease the pain of terminally ill patients, says one doctor

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

Also in TTHealthWatch: tranexamic acid in routine surgery

Study Homes In on Simpler Lung Cancer Screening Criteria

Researchers find benefits, trade-offs using various levels of smoking duration alone

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs

Why Are These Bones and Teeth Where They Shouldn't Be?

Discovery in 31-year-old woman made after she came to the ER with mild abdominal pain

Smoker's Painless Skin Nodules Flag a Fatal Diagnosis

Skin metastasis was the first sign for the otherwise asymptomatic patient

Recommended News For You

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

Clinical trial is testing whether heavy lifting could combat cancer side effects

A study outlines the need for policies that enhance cancer patients' autonomy and information.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Recommended Articles For You

Innovative Advances in Oncology for Specialists 

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients 

Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells 

Rehabilitation of Functional Capacity Following Cancer-Related Prolonged Deconditioning 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

2.

Lower screening age calls for more tailored bowel cancer surveillance

3.

For relapsed or resistant DLBCL, odronextamab produced positive results.

4.

Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening

5.

Study identifies new target for obesity-related breast cancer

1.

Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment

2.

Oncology Treatment: Innovations, Education, and Clinical Practice Insights

3.

Modern Oncology Education in the Era of Targeted Therapies

4.

Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More

5.

Gene Therapy for Hemophilia: A New Hope on the Horizon

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

2.

Innovations in Hematology

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot